These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 16625586

  • 41. Therapies for steroid-resistant nephrotic syndrome.
    Hodson EM, Craig JC.
    Pediatr Nephrol; 2008 Sep; 23(9):1391-4. PubMed ID: 18368428
    [Abstract] [Full Text] [Related]

  • 42. Treatment for lupus nephritis.
    Flanc RS, Roberts MA, Strippoli GF, Chadban SJ, Kerr PG, Atkins RC.
    Cochrane Database Syst Rev; 2004 Sep; (1):CD002922. PubMed ID: 14973998
    [Abstract] [Full Text] [Related]

  • 43. Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    Plank C, Kalb V, Hinkes B, Hildebrandt F, Gefeller O, Rascher W, Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    Pediatr Nephrol; 2008 Sep; 23(9):1483-93. PubMed ID: 18481113
    [Abstract] [Full Text] [Related]

  • 44. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
    Ladapo TA, Esezobor CI, Lesi FE.
    Pan Afr Med J; 2016 Sep; 25():258. PubMed ID: 28293374
    [Abstract] [Full Text] [Related]

  • 45. Immunosuppressive therapy for steroid-resistant nephrotic syndrome: a Bayesian network meta-analysis of randomized controlled studies.
    Jiang X, Shen W, Xu X, Shen X, Li Y, He Q.
    Clin Exp Nephrol; 2018 Jun; 22(3):562-569. PubMed ID: 29080118
    [Abstract] [Full Text] [Related]

  • 46. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J, Ehrich JH, Querfeld U.
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [Abstract] [Full Text] [Related]

  • 47. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [Abstract] [Full Text] [Related]

  • 48. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.
    Webster A, Woodroffe RC, Taylor RS, Chapman JR, Craig JC.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD003961. PubMed ID: 16235347
    [Abstract] [Full Text] [Related]

  • 49. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
    Zhonghua Er Ke Za Zhi; 2014 Mar 19; 52(3):194-200. PubMed ID: 24824389
    [Abstract] [Full Text] [Related]

  • 50. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
    Am J Kidney Dis; 2009 May 19; 53(5):760-9. PubMed ID: 19268410
    [Abstract] [Full Text] [Related]

  • 51. Chinese herbal medicine Huangqi type formulations for nephrotic syndrome.
    Feng M, Yuan W, Zhang R, Fu P, Wu T.
    Cochrane Database Syst Rev; 2013 Jun 05; 2013(6):CD006335. PubMed ID: 23740567
    [Abstract] [Full Text] [Related]

  • 52. Evidence-based management of steroid-sensitive nephrotic syndrome.
    Hodson EM, Craig JC, Willis NS.
    Pediatr Nephrol; 2005 Nov 05; 20(11):1523-30. PubMed ID: 15968558
    [Abstract] [Full Text] [Related]

  • 53. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
    Przegl Lek; 2006 Nov 05; 63 Suppl 3():44-8. PubMed ID: 16898486
    [Abstract] [Full Text] [Related]

  • 54. Immunomodulatory agents for idiopathic pulmonary fibrosis.
    Davies HR, Richeldi L, Walters EH.
    Cochrane Database Syst Rev; 2003 Nov 05; (3):CD003134. PubMed ID: 12917947
    [Abstract] [Full Text] [Related]

  • 55. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
    Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P.
    Nephrol Dial Transplant; 1993 Nov 05; 8(12):1326-32. PubMed ID: 8159300
    [Abstract] [Full Text] [Related]

  • 56. Interventions for preventing infection in nephrotic syndrome.
    Wu HM, Tang JL, Cao L, Sha ZH, Li Y.
    Cochrane Database Syst Rev; 2012 Apr 18; 2012(4):CD003964. PubMed ID: 22513919
    [Abstract] [Full Text] [Related]

  • 57. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
    Podracká L, Böör A, Sasinka M.
    Cas Lek Cesk; 2008 Apr 18; 147(1):38-43. PubMed ID: 18323041
    [Abstract] [Full Text] [Related]

  • 58. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M, Brassington R, Gunn AA, van Doorn PA, Hughes RA.
    Cochrane Database Syst Rev; 2017 May 08; 5(5):CD003280. PubMed ID: 28481421
    [Abstract] [Full Text] [Related]

  • 59. Interventions for renal vasculitis in adults.
    Walters G, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2015 Sep 24; (9):CD003232. PubMed ID: 26400765
    [Abstract] [Full Text] [Related]

  • 60. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov 24; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.